Coordinate autophagy and mTOR pathway inhibition enhances cell death in melanoma

Area of Science:

• Oncology
• Cell Biology
• Molecular Medicine

Background:

• The PI3K/AKT/mTOR pathway fuels melanoma growth and survival by suppressing autophagy.
• Autophagy inhibition by mTOR inhibitors can paradoxically promote tumor survival, limiting treatment efficacy.
• Melanoma cells rely on autophagy for survival, making it a potential therapeutic target.

Purpose of the Study:

• To investigate if combining mTOR and autophagy inhibition enhances melanoma cell death.
• To determine if blocking autophagy can overcome resistance to mTOR inhibitors in melanoma.

Main Methods:

• Utilized multiple melanoma cell lines with varying genotypes.
• Knocked down the essential autophagy gene ATG7 to assess autophagy dependence.
• Treated cells with the mTOR inhibitor temsirolimus (CCI-779) and the autophagy inhibitor hydroxychloroquine (HCQ).
• Evaluated cell death via apoptosis in 3D spheroid cultures and tumor xenografts.

Main Results:

• Melanoma cell lines showed high basal autophagy levels.
• ATG7 knockdown led to melanoma cell death, confirming autophagy dependence.
• Hydroxychloroquine (HCQ) synergized with temsirolimus (CCI-779), inducing apoptosis and cell death.
• Combination therapy suppressed tumor growth in both spheroid and xenograft models.

Conclusions:

• Coordinate inhibition of mTOR and autophagy pathways is a promising strategy for melanoma treatment.
• This dual inhibition promotes apoptosis and overcomes tumor survival mechanisms.
• The combination of mTOR and autophagy inhibitors represents a potential new therapeutic paradigm for melanoma.